Veracyte (VCYT) Accounts Payables (2012 - 2026)

Veracyte has disclosed Accounts Payables across 15 years of filings, most recently posting $6.9 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $6.9 million, down 56.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 million (down 56.03% YoY), and the FY2025 annual result was $4.6 million, down 46.8% from the prior year.
• Accounts Payables came in at $6.9 million for Q1 2026 at Veracyte, up from $4.6 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $15.7 million in Q1 2025 to a low of $4.6 million in Q4 2025.
• The 5-year median for Accounts Payables is $11.4 million (2025), against an average of $10.9 million.
• Across the five-year window, Accounts Payables soared 57.95% in 2022 and tumbled 56.03% in 2026, its largest moves.
• Veracyte's Accounts Payables stood at $11.9 million in 2022, then advanced by 8.66% to $12.9 million in 2023, then plunged by 33.29% to $8.6 million in 2024, then tumbled by 46.8% to $4.6 million in 2025, then jumped by 50.4% to $6.9 million in 2026.
• The last three Accounts Payables figures came in at $6.9 million (Q1 2026), $4.6 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.